Effects of scopolamine on visual evoked potentials in aging and dementia. 1991

P G Ray, and K J Meador, and D W Loring, and A M Murro, and J J Buccafusco, and X H Yang, and E Y Zamrini, and W O Thompson, and E E Thompson
Department of Neurology, Medical College of Georgia, Augusta 30912.

The unusual combination of a normal pattern reversal VEP and a delayed flash VEP has been reported in patients with dementia of Alzheimer's type (DAT). Hyoscine hydrobromide has been reported to produce a similar VEP abnormality in young, healthy subjects. In the present study, we assessed the relative sensitivity of DAT patients and healthy young, middle-aged and elderly subjects to temporary cholinergic blockade. We report VEP latency values following 3 doses of scopolamine and after a peripheral anticholinergic agent. Flash P2 latency was not significantly slower in DAT patients than in the healthy elderly. Scopolamine increased P2 latency in the young controls but did not affect any other group. The pattern reversal P100 was normal in DAT, and a significant increase in latency occurred following scopolamine administration in both the control and patient groups.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D010364 Pattern Recognition, Visual Mental process to visually perceive a critical number of facts (the pattern), such as characters, shapes, displays, or designs. Recognition, Visual Pattern,Visual Pattern Recognition
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005074 Evoked Potentials, Visual The electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways. Visual Evoked Response,Evoked Potential, Visual,Evoked Response, Visual,Evoked Responses, Visual,Potential, Visual Evoked,Potentials, Visual Evoked,Response, Visual Evoked,Responses, Visual Evoked,Visual Evoked Potential,Visual Evoked Potentials,Visual Evoked Responses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging

Related Publications

P G Ray, and K J Meador, and D W Loring, and A M Murro, and J J Buccafusco, and X H Yang, and E Y Zamrini, and W O Thompson, and E E Thompson
January 1990, Psychopharmacology,
P G Ray, and K J Meador, and D W Loring, and A M Murro, and J J Buccafusco, and X H Yang, and E Y Zamrini, and W O Thompson, and E E Thompson
January 2000, Vojnosanitetski pregled,
P G Ray, and K J Meador, and D W Loring, and A M Murro, and J J Buccafusco, and X H Yang, and E Y Zamrini, and W O Thompson, and E E Thompson
March 1995, Optometry and vision science : official publication of the American Academy of Optometry,
P G Ray, and K J Meador, and D W Loring, and A M Murro, and J J Buccafusco, and X H Yang, and E Y Zamrini, and W O Thompson, and E E Thompson
July 2013, International journal of psychophysiology : official journal of the International Organization of Psychophysiology,
P G Ray, and K J Meador, and D W Loring, and A M Murro, and J J Buccafusco, and X H Yang, and E Y Zamrini, and W O Thompson, and E E Thompson
January 1983, Electromyography and clinical neurophysiology,
P G Ray, and K J Meador, and D W Loring, and A M Murro, and J J Buccafusco, and X H Yang, and E Y Zamrini, and W O Thompson, and E E Thompson
May 2015, Muscle & nerve,
P G Ray, and K J Meador, and D W Loring, and A M Murro, and J J Buccafusco, and X H Yang, and E Y Zamrini, and W O Thompson, and E E Thompson
December 1987, Documenta ophthalmologica. Advances in ophthalmology,
P G Ray, and K J Meador, and D W Loring, and A M Murro, and J J Buccafusco, and X H Yang, and E Y Zamrini, and W O Thompson, and E E Thompson
January 1982, Advances in neurology,
P G Ray, and K J Meador, and D W Loring, and A M Murro, and J J Buccafusco, and X H Yang, and E Y Zamrini, and W O Thompson, and E E Thompson
July 2005, The International journal of neuroscience,
P G Ray, and K J Meador, and D W Loring, and A M Murro, and J J Buccafusco, and X H Yang, and E Y Zamrini, and W O Thompson, and E E Thompson
December 1990, Electromyography and clinical neurophysiology,
Copied contents to your clipboard!